What factors are contributing to the unexpected 30% rise in manufacturing costs for Baxter International's Prismaflex dialysis machines in the last six months?

Introduction

The unexpected 30% rise in manufacturing costs for Baxter International's Prismaflex dialysis machines over the last six months is a critical issue that demands immediate attention. To address this problem, I'll employ a systematic approach to identify, validate, and resolve the root cause while considering both short-term and long-term implications for the product and company.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might be a specific event or change that triggered this cost increase. Has there been any major change in the manufacturing process or supply chain in the last 6-8 months?

Why it matters: Identifying a specific trigger could help narrow down the root cause quickly. Expected answer: Yes, we switched to a new supplier for a key component. Impact on approach: If true, I'd focus on supplier-related issues; if not, I'd look at broader systemic changes.

• Considering the magnitude of the increase, I'm wondering if this affects all Prismaflex models equally. Are we seeing the 30% increase across all product variants, or is it concentrated in specific models?

Why it matters: This helps determine if the issue is universal or specific to certain product lines. Expected answer: The increase is more pronounced in our newer, high-end models. Impact on approach: If concentrated, I'd investigate unique features or components of affected models.

• Given the complexity of dialysis machines, I'm curious about the breakdown of this cost increase. Can you provide a high-level breakdown of where we're seeing the most significant cost jumps - materials, labor, overhead, or something else?

Why it matters: This helps prioritize areas for investigation and potential cost-saving measures. Expected answer: The majority of the increase is in materials costs. Impact on approach: I'd focus on material sourcing and potential alternatives if this is the case.

• Considering potential external factors, has there been any significant change in regulatory requirements or industry standards that might be driving up costs?

Why it matters: External factors could be beyond our immediate control but crucial to understand. Expected answer: No major regulatory changes, but there's been increased scrutiny on quality control. Impact on approach: If true, I'd look into quality control processes and their associated costs.